FDA meeting to pick next winter's flu shot is canceled, in ominous sign for US

Perceived political / ideological motives

• Many see no legitimate strategy, interpreting the cancellation as part of a broader project to weaken or dismantle federal institutions, reduce social spending, and privatize health-related functions.
• Others link it to long-standing goals in one party to shrink government roles in education and healthcare and to favor large corporate interests.
• A minority tries to “steelman” the move as driven by skepticism about vaccine efficacy, safety, or cost-effectiveness, though this is strongly disputed.

Role of current health leadership and anti‑vaccine views

• Several comments tie the decision directly to having an outspoken anti-vaccine figure in charge of federal health, describing him as sincerely believing he is preventing “vaccine injury.”
• There is disagreement over his personal medical history and whether he attributes his condition to vaccines, but consensus that his rhetoric fuels wider anti-vax sentiment.

Vaccines, natural immunity, and herd immunity

• Long subthreads debate whether letting populations rely on “natural immunity” could ultimately strengthen them, versus the view that this would predictably mean many more deaths and disabilities.
• Some argue that mortality from diseases like measles was already falling before vaccines, implying environment and nutrition matter greatly; others counter that vaccines clearly drove eradication/near-eradication.
• Herd immunity’s real-world thresholds and evidence are contested: some say it’s well-supported in principle but not rigorously quantified for policy; others insist it’s established enough to justify high coverage.

Practical impact of canceling the flu-strain meeting

• Commenters stress the meeting’s timing sensitivity: strain selection feeds a roughly six‑month manufacturing cycle, so delays can degrade effectiveness or eliminate the next season’s US-specific vaccine.
• Explanation is given that this coordination—based partly on opposite-hemisphere surveillance—is something governments are good at and companies alone are not.
• Some hope manufacturers, states, or other countries will step in, but expect higher costs, delays, or reliance on non‑US decision-making.

Bird flu, culling, and pandemic risk

• A side debate covers industrial agriculture as a source of zoonotic risk, and whether mass culling of poultry is justified without definitive proof of bird‑to‑human transmission.
• One side trusts public-health agencies’ precautionary stance; the other criticizes them for making strong claims without controlled transmissibility studies.

Hysteria vs. complacency

• Some accuse media and commenters of “hysteria” over a single canceled meeting, suggesting it may be rescheduled or overinterpreted.
• Others respond that short-notice cancellation with no new date, in the context of explicit anti-vax leadership, is exactly the sort of situation where alarm is warranted.